Trademark Overview
On Tuesday, August 24, 2021, a trademark application was filed for DAIM with the United States Patent and Trademark Office. The USPTO has given the DAIM trademark a serial number of 90898772. The federal status of this trademark filing is REGISTERED as of Tuesday, November 22, 2022. This trademark is owned by Daim Pharma Ltd. The DAIM trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Advertising, Business and Retail Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; all of the aforesaid goods being for the diagnosis, treatment, management or prevention of Type 1 diabetes
Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases; all of the aforesaid services being provided in connection with the diagnosis, treatment, management or prevention of Type 1 diabetes
Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services in the field of diabetes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic testing services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis; all of the aforesaid services relating to the diagnosis, treatment, management or prevention of Type 1 diabetes
Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes, namely, monitoring glucose level; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes, namely, for diabetes testing; Diagnostic, examination, and monitoring equipment, namely, blood glucose monitor; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments for monitoring glucose levels; Medical diagnostic instruments for measuring glucose levels in blood; Medical testing instruments for recording blood glucose levels; all of the aforesaid goods being for use in the diagnosis, treatment, management or prevention of Type 1 diabetes
